Under the blood analysis it is possible to predict a mu ...

In article published in magazine Neurology, scientists from the London Institute of Neurology and Institute of Cellular and Molecular Biology have described the analysis of blood which can predict a multiple sclerosis current.
Researchers estimated level of various antibodies to a virus Epstein-Barr in blood serum of patients with a multiple sclerosis. The given virus widespread in human population, therefore antibodies to it are taped at many adult patients with a multiple sclerosis. There was, however, that a level of one of types of antibodies to a virus, so-called anti - EBNA-1 IgG, directly is bound to activity of disease.
Authors of research do the conclusion that anti-EbNa-1 IgG - the first biomarker, which can potentially be used for definition of probability of development of disease after occurrence of the first symptoms (the so-called clinically isolated syndrome, suspicious on multiple sclerosis development), and also for the forecast of advance of an invalidism. Carrying out of the given analysis can help to tap people at whom with larger probability and the multiple sclerosis will fast develop and to define more effective therapy for each concrete patient.
In too time, authors of article specify in necessity of the further researches with a considerable quantity of patients for validatrionreceived results and, probably, search new, while not identified, multiple sclerosis biomarkers

Drug Search